Difficulty: Medium
Average Score: 95%
Practice
Correct statements about etidronate include all of the following, EXCEPT:
Correct answer
C
Rationale
In this question, the correct answer is C) 2nd generation bisphosphonate (amino-bisphosphonate) as being incorrect about etidronate. Etidronate is a 1st generation bisphosphonate, not a 2nd generation one.
Etidronate has a skeletal half-life of around 100 days, making statement A correct. Statement B is incorrect because the bioavailability of etidronate decreases with increasing doses due to non-linear absorption kinetics. Statement D is correct as etidronate is indeed classified as a 1st generation bisphosphonate.
Educationally, understanding the classification and characteristics of bisphosphonates like etidronate is crucial for pharmacology students and healthcare professionals. Knowing the differences between generations of bisphosphonates helps in selecting appropriate medications for osteoporosis and other bone-related conditions based on factors like efficacy, side effect profiles, and patient-specific considerations.
Etidronate has a skeletal half-life of around 100 days, making statement A correct. Statement B is incorrect because the bioavailability of etidronate decreases with increasing doses due to non-linear absorption kinetics. Statement D is correct as etidronate is indeed classified as a 1st generation bisphosphonate.
Educationally, understanding the classification and characteristics of bisphosphonates like etidronate is crucial for pharmacology students and healthcare professionals. Knowing the differences between generations of bisphosphonates helps in selecting appropriate medications for osteoporosis and other bone-related conditions based on factors like efficacy, side effect profiles, and patient-specific considerations.